FDA Adverse Event Injury Summary report: N

SONATA TRANSCERVICAL FIBROID ABLATION SYSTEM

MDR report key: 22952748 · Received September 3, 2025

Report

Report Number
3005875675-2025-00041
Event Type
Injury
Date Received
September 3, 2025
Date of Event
May 8, 2023
Report Date
September 3, 2025
Manufacturer
GYNESONICS
Product Code
KNF
UDI-DI
10817929020333
PMA / PMN Number
K222304
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
AU
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

THERE WAS NO REPORT OF DEVICE MALFUNCTION DURING THE PROCEDURE AN THE SYSTEM FUNCTIONED AS EXPECTED. SUBMISSION OF THIS REPORT IS ASSOCIATED WITH THE RECENT ACQUISITION OF GYNESONICS BY HOLOGIC, INC. DURING THE INTEGRATION INTO HOLOGIC'S ADVERSE EVENT REPORTING SYSTEM AND PROCEDURES, A REVIEW OF HISTORICAL ADVERSE EVENTS WAS PERFORMED. AS A RESULT, THIS EVENT WAS IDENTIFIED AS BEING REPORTABLE ON (B)(6) 2025 AND IS BEING REPORTED RETROACTIVELY OUT OF AN ABUNDANCE OF CAUTION.

Description of Event or Problem · 0

ON (B)(6) 2023, IT WAS INITIALLY REPORTED TO GYNESONICS THAT A PATIENT WHO WAS TREATED WITH THE SONATA SYSTEM WAS ADMITTED TO THE ICU OF A SEPARATE HOSPITAL FOR PRESUMPTIVE SEPSIS. PER ADDITIONAL INFORMATION RECEIVED ON (B)(6) 2023, DOCTOR INFORMED GYNESONICS MEDICAL DIRECTOR THAT THE PATIENT HAD A "LARGE" FIBROID AND IT WAS INITIALLY RESECTED THEN ABLATED. 1-2 WEEKS LATER THE PATIENT WAS SEEN IN AN ER FOR PAIN AND SHE WAS SENT HOME ON MEDS (ANTIBIOTICS). A FEW DAYS LATER SHE PRESENTED AGAIN AT AN OUTSIDE HOSPITAL, SHE WAS ADMITTED FOR AN INFECTION, AND SHE UNDERWENT A HYSTERECTOMY PROCEDURE. AS OF THE DATE THIS INFORMATION WAS REPORTED, PATIENT STILL IN THE ICU. NO FURTHER INFORMATION WAS REPORTED REGARDING THE STATUS OF THE PATIENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1733907 SONATA TRANSCERVICAL FIBROID ABLATION SYSTEM ULTRASOUND-GUIDED INTRAUTERINE RADIO-FREQUENCY ABLATION SYSTEM KNF GYNESONICS SONATA2-220 10817929020333

Patients

Seq Age Sex Outcome Treatment
1 NA Female Required Intervention